Crowdonomics
This isn’t Eliaz Therapeutics’s most recent raise. Reg CF · Class B Common Stock · Jun 2026 (Open) is more current.View latest round
Eliaz Therapeutics

Reg CF · Class B Common Stock · Dec 2025

ClosedReached targetReg CFCommon Equity
via StartEngine · last checked Oct 4, 2026View campaign
Raised
$470.1K / $2.5M max
19% of ceiling
Investors
338
$1.9K avg
Post-money valuation
$60.1M
pre-money + amount raised

Financials disclosed in this offering

FY2023–FY2024 · hover for source
$0
−$548K
FY2023
$302K
−$955K
FY2024
RevenueNet income
Metric
FY2023 audited
FY2024 audited
Income statement
Revenue
$0
$302,481
Cost of goods sold
$0
$0
Gross margin
—
100%
Net income
-$548,405
-$954,869
Taxes paid
$0
$0
Balance sheet
Cash
$4,886
$32,814
Accounts receivable
$0
$0
Total assets
$803,385
$738,015
Short-term debt
$1,566,203
$2,346,085
Long-term debt
$3,782,811
$3,888,186
Total liabilities
$5,349,014
$6,234,271
Other
Headcount
1
5

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

1 amendment
  1. Mar 3, 2026
    • Deadline Mar 9, 2026 → Apr 30, 2026

    “Campaign is Extending to April 30 2026 and adding flash perks”

    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Pre-money$59.4M
Post-money$60.1M
Price / share$5.56
Shares offered3,597

Perks

Early Bird 1: $2,000+ · 2% bonus shares · until Dec 21, 20252% bonus$2K+
Early Bird 2: $5,000+ · 3% bonus shares · until Dec 21, 20253% bonus$5K+
Early Bird 3: $10,000+ · 5% bonus shares · until Dec 21, 20255% bonus$10K+
Early Bird 4: $20,000+ · 7% bonus shares · until Dec 21, 20257% bonus$20K+
Early Bird 5: $50,000+ · 10% bonus shares · until Dec 21, 202510% bonus$50K+
Flash Perk 1: $2,000+ · 2% bonus shares · Jan 11, 2026 – Jan 16, 20262% bonus$2K+
Flash Perk 2: $5,000+ · 3% bonus shares · Jan 11, 2026 – Jan 16, 20263% bonus$5K+
Flash Perk 3: $10,000+ · 5% bonus shares · Jan 11, 2026 – Jan 16, 20265% bonus$10K+
Flash Perk 4: $20,000+ · 6% bonus shares · Jan 11, 2026 – Jan 16, 20266% bonus$20K+
Flash Perk 5: $50,000+ · 7% bonus shares · Jan 11, 2026 – Jan 16, 20267% bonus$50K+
Flash Perk 6: $2,000+ · 1% bonus shares · Feb 5, 2026 – Feb 10, 20261% bonus$2K+
Flash Perk 7: $5,000+ · 2% bonus shares · Feb 5, 2026 – Feb 10, 20262% bonus$5K+
Flash Perk 8: $10,000+ · 3% bonus shares · Feb 5, 2026 – Feb 10, 20263% bonus$10K+
Flash Perk 9: $20,000+ · 5% bonus shares · Feb 5, 2026 – Feb 10, 20265% bonus$20K+
Flash Perk 10: $50,000+ · 6% bonus shares · Feb 5, 2026 – Feb 10, 20266% bonus$50K+
Flash Perk 11: $2,000+ · 1% bonus shares · Apr 25, 2026 – Apr 30, 20261% bonus$2K+
Flash Perk 12: $5,000+ · 2% bonus shares · Apr 25, 2026 – Apr 30, 20262% bonus$5K+
Flash Perk 13: $10,000+ · 3% bonus shares · Apr 25, 2026 – Apr 30, 20263% bonus$10K+
Flash Perk 14: $20,000+ · 5% bonus shares · Apr 25, 2026 – Apr 30, 20265% bonus$20K+
Flash Perk 15: $50,000+ · 6% bonus shares · Apr 25, 2026 – Apr 30, 20266% bonus$50K+
— 1% bonus shares1% bonus$5K+
— 2% bonus shares2% bonus$10K+
— 3% bonus shares3% bonus$20K+
— 5% bonus shares5% bonus$50K+

Offering details

Target$19,999
Max$2,490,574
Min investment—
OpenedDec 8, 2025
DeadlineApr 30, 2026
ClosedApr 30, 2026
Days active143

Links & provenance

Source: SEC EDGAR
0002042609-25-000007
Last synced Aug 18, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.